comparemela.com

Latest Breaking News On - Otsuka pharmaceuticals - Page 5 : comparemela.com

Daiya appoints Hajime Fujita as CEO - FoodBev Media

Daiya appoints Hajime Fujita as CEO - FoodBev Media
foodbev.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foodbev.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
Canada
British
America
John-kelly
Melanie-domer
Hajime-fujita
Michael-watt
Otsuka-pharmaceuticals
Daiya-foods
North-america

Daiya appoints new CEO - Canadian Manufacturing

Chief Marketing Officer, Melanie Domer will assume a new role as Chief Commercial Officer, overseeing marketing and sales while John Kelly, VP, Consumer Marketing assumes the role of Chief Marketing Officer.

United-kingdom
Vancouver
British-columbia
Canada
British
Hajime-fujita
John-kelly
Otsuka-america
Melanie-domer
Otsuka-pharmaceuticals
Daiya-foods
Chief-executive

Plant-based dairy group Daiya Foods appoints new CEO

Hajime Fujita had previously worked at Daiya Foods as director for financial planning and analysis from 2018 to 2021.

Canada
United-kingdom
United-states
Indonesia
China
Japan
America
Canadian
British
Hajime-fujita
Michael-watt
Japan-otsuka-pharmaceuticals

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2023 Earnings Call Transcript

Operator: Greetings. Welcome to Aurinia Pharmaceuticals Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Switzerland
Canada
United-kingdom
Japan
United-states
American
Swiss
Canadian
British
Jamie-harrell
Toni-braxton
Farzin-haque

ENVISION Trial: Sibeprenlimab Reduces 24-Hour UACR in IgA Nephropathy

Presented at ASN Kidney Week 2023, results of the ENVISION trial provide the latest insight into effects of sibeprenlimab in management of IgA nephropathy as the nephrology community awaits the results of its ongoing phase 3 trial.

United-states
American
Otsuka-pharmaceuticals
American-society-of-nephrology-kidney-week
American-society
Kidney-week
Otsuka-pharmaceutical
Acquire-visterra
Sibeprenlimab
Iga-nephropathy
Berger-disease

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.